ACTYM THERAPEUTICS, INC.

actym-therapeutics-inc-logo

Actym Therapeutics, based in Berkeley, CA, is a privately-held biotechnology company focused on discovery and development of novel immuno-oncology therapies to treat cancer. The company has developed an attenuated, microbial-based, immunotherapeutic technology platform called STACT (S. Typhimurium-Attenuated Cancer Therapy). In preclinical studies, STACT specifically enriches in many types of solid tumors and not in healthy tissue. Once there, STACT delivers multiplexed immuno-modulatory payload... s directly to tumor-resident immune cells. Many of these payload targets are of significant interest to the biopharmaceutical community but are intractable using conventional approaches due to systemic toxicities after intravenous dosing. Furthermore, STACT has been engineered to deliver payload combinations, which facilitates engagement of multiple biological pathways from a single therapy. In April of 2020, Actym raised $34 million in a Series A financing, co-led by Boehringer-Ingelheim Venture Fund and Panacea Venture Healthcare, with participation from Illumina Ventures, Korea Investment Partners, and JLO Ventures.

#SimilarOrganizations #People #Financial #Event #Website #More

ACTYM THERAPEUTICS, INC.

Industry:
Biotechnology Medical Medical Device

Founded:
2017-05-01

Address:
Berkeley, California, United States

Country:
United States

Website Url:
http://www.actymthera.com

Total Employee:
11+

Status:
Active

Total Funding:
34 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network


Similar Organizations

asklepios-biopharmaceutical-logo

Asklepios BioPharmaceutical

Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.

anchiano-therapeutics-logo

Anchiano Therapeutics

Anchiano is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer.

capsulomics-logo

Capsulomics

Capsulomics Inc. is a life sciences company focused on the development and commercialization of diagnostic tests for cancer prevention.

dice-therapeutics-logo

Dice Therapeutics

Dice Therapeutics develops a transformative platform designed for the discovery of novel small molecules.

northwest-biotherapeutics-logo

Northwest Biotherapeutics

Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.

piqur-therapeutics-logo

PIQUR Therapeutics

PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.


Current Advisors List

alexis-yongmei-ji_image

Alexis Yongmei Ji Board Member @ Actym Therapeutics, Inc.
Board_member
2020-04-27

kanad-das_image

Kanad Das Board Member @ Actym Therapeutics, Inc.
Board_member
2020-04-27

Current Employees Featured

christopher-thanos_image

Christopher Thanos
Christopher Thanos President, CEO, and Cofounder @ Actym Therapeutics, Inc.
President, CEO, and Cofounder
2017-01-01

laura-hix-glickman_image

Laura Hix Glickman
Laura Hix Glickman Vice President, Research & Cofounder @ Actym Therapeutics, Inc.
Vice President, Research & Cofounder
2017-06-01

Founder


amit-kumar_image

Amit Kumar

christopher-thanos_image

Christopher Thanos

laura-hix-glickman_image

Laura Hix Glickman

Investors List

korea-investment-partners_image

Korea Investment Partners

Korea Investment Partners investment in Series A - Actym Therapeutics, Inc.

illumina-ventures_image

Illumina Ventures

Illumina Ventures investment in Series A - Actym Therapeutics, Inc.

jlo-ventures_image

JLo Ventures

JLo Ventures investment in Series A - Actym Therapeutics, Inc.

boehringer-ingelheim-venture-fund_image

Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund investment in Series A - Actym Therapeutics, Inc.

panacea-venture_image

Panacea Venture

Panacea Venture investment in Series A - Actym Therapeutics, Inc.

intellectus-partners-llc_image

Intellectus Partners

Intellectus Partners investment in Seed Round - Actym Therapeutics, Inc.

Key Employee Changes

Date New article
2021-11-11 Actym Therapeutics Appoints Chan Whiting as Chief Development Officer

Official Site Inspections

http://www.actymthera.com Semrush global rank: 2.87 M Semrush visits lastest month: 5.66 K

  • Host name: unalocated.63.wixsite.com
  • IP address: 185.230.63.107
  • Location: Ashburn United States
  • Latitude: 39.018
  • Longitude: -77.539
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20147

Loading ...

More informations about "Actym Therapeutics, Inc." on Search Engine